Indacaterol
The First Once-daily Long-acting Beta2 Agonist for COPD
Produktform: E-Buch Text Elektronisches Buch in proprietärem
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled β2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.
96,29 € inkl. MwSt.
Recommended Retail Price
kostenloser Versand
lieferbar - Lieferzeit 10-15 Werktage
Indacaterol
The First Once-daily Long-acting Beta2 Agonist for COPD
Produktform: Buch / Einband - fest (Hardcover)
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled β2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.
106,99 € inkl. MwSt.
kostenloser Versand
lieferbar - Lieferzeit 10-15 Werktage